Winter Charles M.
Chief Technical Officer
Winter Charles M. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 2, 2026.
On the most recent filing, Winter Charles M. is listed as Chief Technical Officer at Janux Therapeutics, Inc. Inside the rolling window, Winter Charles M. reported no open-market purchases and 1 open-market sale totaling $33K in JANX.
Companies traded
Other insiders at JANX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$33K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Winter Charles M. made?
Winter Charles M. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Winter Charles M. trade?
Winter Charles M. has filed SEC Form 4 disclosures for 1 company, including JANX.
When was Winter Charles M.'s most recent SEC Form 4 filing?
Winter Charles M.'s most recent SEC Form 4 filing on Tracefour is dated Jan 2, 2026.
What is Winter Charles M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Winter Charles M. is listed as Chief Technical Officer.
What is Winter Charles M.'s total buy and sell value in the current window?
Inside the rolling retention window, Winter Charles M. bought $0 and sold $33K based on SEC Form 4 filings.
What was Winter Charles M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,401 JANX shares on 2026-01-02, worth $33K, per SEC Form 4 filings.